FIGURE

Figure 8

ID
ZDB-FIG-221214-135
Publication
Poudel et al., 2022 - Resveratrol-Mediated Reversal of Doxorubicin-Induced Osteoclast Differentiation
Other Figures
All Figure Page
Back to All Figure Page
Figure 8

Reversal of Doxorubicin-induced mucositis by resveratrol. The ctsk reporter zebrafish transgenic line (Tg[ctsk:DsRed]) was exposed to different concentrations of resveratrol (RES, 75 µM and 100 µM) alone or together with doxorubicin (DOX, 17.2 µM) for 96 h. The quantification of fluorescence intensity between the treatment groups performed using fluorescent images acquired with the same parameters and analyzed with ImageJ (A). ctsk signal in the abdominal area of fish from the different treatment groups (B). One-way ANOVA, Tukey’s multiple comparisons test, *—p ≤ 0.05, ****—p ≤ 0.0001.

Expression Data
Gene:
Fish:
Conditions:
Anatomical Term:
Stage: Days 21-29

Expression Detail
Antibody Labeling
Phenotype Data
Fish:
Conditions:
Observed In:
Stage: Days 21-29

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Int. J. Mol. Sci.